MedPath

Efficacy of Using Mobile Health Applications for Health

Not Applicable
Recruiting
Conditions
Diabetes Mellitus, Type 2
Obesity
Interventions
Other: Mobile health application
Registration Number
NCT05589155
Lead Sponsor
San Diego State University
Brief Summary

The purpose of this study is to determine the effectiveness of mobile health applications in improving health outcomes and type II diabetes outcomes in type 2 diabetics. This study will involve a 6-month long commitment where participants will be expected to weigh themselves every morning, at the same time, and check their blood glucose readings daily before and after meals for at least three meals in the day.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
30
Inclusion Criteria
  • Diagnosed with type II diabetes for at least 3 months
  • Between the age of 18-64
  • BMI ≥ 25
  • Monitors blood glucose regularly (at least once per day)
  • Owns or has access to a bathroom weight scale
  • Owns a smartphone and willing to download mobile app
Exclusion Criteria
  • Does not check blood glucose at least once per day
  • On medications that promote weight gain such as antipsychotic, antidepressant, and steroid hormone medications.

Medications for diabetes such as insulin, thiazolidinediones or sulfonylureas are oka

Study & Design

Study Type
INTERVENTIONAL
Study Design
FACTORIAL
Arm && Interventions
GroupInterventionDescription
HealthiMobile health application-
Primary Outcome Measures
NameTimeMethod
Self-efficacy in weight management assessed by Weight Management and Nutrition Knowledge questionnaire6 months

Compare and determine which intervention promotes self-efficacy in weight management.

Reporting will be on a scale of 0-100, with higher scores indicating higher self-efficacy

Effectiveness of mHealth apps at changing bodyweight assessed by bodyweight measurements over 6 months6 months

Determine if mhealth app is an effective weight loss modality compared to standard weight loss program (control)

Outcome measure will be body weight in kg

Long term change in diabetes via A1c6 months

Compare and determine which intervention elicits the most change towards diabetes via HbA1c

Outcome measure will be HbA1c

Long term change in diabetes via fasting blood glucose6 months

Compare and determine which intervention elicits the most change towards diabetes via fasting blood glucose

Outcome measure will be fasting blood glucose

Secondary Outcome Measures
NameTimeMethod
Quality of Life after using mHealth apps assessed by World Health Organization Quality of Life BREF questionnaire6 months

Comparing the two arms to determine which leads to greater quality of life (QOL)

Measures will be reported on a scale of 1-5 across four domains. Scores will be converted to a scale of 0-100

Trial Locations

Locations (1)

San Diego State University

🇺🇸

San Diego, California, United States

© Copyright 2025. All Rights Reserved by MedPath